BIBLIOS

Tipo
Artigos em Revista

Tipo de Documento
Artigo Completo

Título
Combining Phototherapy and Gold-Based Nanomaterials: A Breakthrough in Basal Cell Carcinoma Treatment

Participantes na publicação
Karolyne Silva Baioco (Author)
Raquel Pereira (Author)
Tânia Ferreira-Gonçalves (Author)
João M. P. Coelho (Author)
Dep. Física
IBEB
Maria Manuela Gaspar (Author)
Catarina Pinto Reis (Author)

Resumo
Basal cell carcinoma (BCC) is the most common type of skin carcinoma worldwide. BCC development is the result of a complex interaction between environmental, phenotypic, and genetic factors. While conventional treatments such as surgery and topical therapies have demonstrated variable efficacy (some of them with limited efficacy), they are not free of adverse side effects, most of them debilitating. Thus, there is a notable gap in the literature regarding alternative and non-invasive therapeutic options. This review aims to address this gap, exploring the potential of photothermal therapy (PTT) combined with metallic nanoparticles, namely gold nanoparticles (AuNPs), as a minimally invasive treatment approach. Through a comprehensive review of the literature in the period from 2014 to 2024, using experimental investigations, this review seeks to elucidate the intricate interplay between genetic factors, environmental influences, and the tumor microenvironment in BCC disease progression, with PTT as a potential therapeutic strategy. Those studies confirmed an enhanced targeting of cancer cells and selective ablation of tumor tissue, using emerging technologies like PTT. A significant tumor reduction, often exceeding 50%, was observed, with some studies reporting complete elimination of the tumor. The main adverse effects noted were localized skin irritation and transient hyperpigmentation, but these were generally minimal and manageable, highlighting the promise of PTT as an effective treatment. Thus, by leveraging the unique properties of AuNPs to enhance the effectiveness of PTT, the targeting of cancer cells can more precisely occur, reducing collateral damage to healthy tissues. This approach not only aims to achieve better clinical results, but also contributes to the broader knowledge base in the field of BCC research. Continued research and clinical trials will be crucial in refining those techniques and validating their efficacy, ultimately paving the way for more effective and less invasive treatments for BCC.


Suporte
International Journal of Molecular Sciences

Identificadores da Publicação
ISSN - 1422-0067

Editora
MDPI AG



Identificadores do Documento
DOI - https://doi.org/10.3390/ijms252111494
URL - http://dx.doi.org/10.3390/ijms252111494

Identificadores de Qualidade
SCIMAGO Q1 (2023) - 1.18 - Medicine (Miscellaneous)